SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001437749-20-013341
Filing Date
2020-06-17
Accepted
2020-06-17 17:15:23
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A navb20200616_s1a.htm S-1/A 455098
2 EXHIBIT 5.1 ex_190719.htm EX-5.1 9335
3 EXHIBIT 23.1 ex_190663.htm EX-23.1 2938
4 a1.jpg GRAPHIC 12934
5 a2.jpg GRAPHIC 12613
6 navlogo01.jpg GRAPHIC 5578
  Complete submission text file 0001437749-20-013341.txt   511659
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-238911 | Film No.: 20970507
SIC: 2835 In Vitro & In Vivo Diagnostic Substances